Effects of Combination Therapy of a CDK4/6 and MEK Inhibitor in Diffuse Midline Glioma Preclinical Models
Yusuke Tomita(Northwestern University), Oren J. Becher(Icahn School of Medicine at Mount Sinai)
Cited by 1
Related Papers
Pediatric high-grade glioma: biologically and clinically in need of new thinking
|Neuro-Oncology|2016|365
Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications
|Acta Neuropathologica|2014|357
Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models
|PLoS ONE|2017|186
PD-0332991, a CDK4/6 Inhibitor, Significantly Prolongs Survival in a Genetically Engineered Mouse Model of Brainstem Glioma
|PLoS ONE|2013|163
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
|Nature Communications|2019|143